Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AllianceBernstein Holding LP AB

Financial Services Asset Management
AllianceBernstein Holding L.P. is a global investment management company. The Company provides diversified investment management, research, and related services to a range of clients. Its principal services include Institutional Services, Retail Services, Private Wealth Management Services and Bernstein Research Services. It offers Institutional Services to its institutional clients, which... see more

Recent & Breaking News (NYSE:AB)

AB Science provides a summary of the key points of the web conference held on 08 April 2016 on masitinib in the treatment of amyotrophic lateral sclerosis.

GlobeNewswire April 11, 2016

AB Science will host live webcast on phase 3 interim analysis in ALS on 8 April 2016, from 5.30pm to 6.30pm CET

GlobeNewswire April 6, 2016

AB Science Announces Positive Interim Results from Phase 3 Trial of Masitinib in Amyotrophic Lateral Sclerosis (ALS)

GlobeNewswire April 4, 2016

AB adds Industry Veteran ERISA Legal Counsel Karen Scheffler

PR Newswire March 22, 2016

AB Science : New independent publications underscore the potential of masitinib in neurological and neurodegenerative diseases

GlobeNewswire March 10, 2016

AB Announces February 29, 2016 Assets Under Management

PR Newswire March 9, 2016

Peter S. Kraus, Chairman and CEO, to Participate in the Citi Asset Management and Broker Dealer Investor Conference on March 3

PR Newswire February 25, 2016

GICSA Announces Consolidated Results for Fourth Quarter 2015

Business Wire February 23, 2016

AB Announces January 31, 2016 Assets Under Management

PR Newswire February 11, 2016

AllianceBernstein Holding L.P. Announces Fourth Quarter Results

PR Newswire February 11, 2016

AB Science announces that Rapporteurs appointed by the EMA have recommended to file a marketing authorization application for full approval for masitinib in severe systemic mastocytosis

GlobeNewswire February 1, 2016

AB to Report Fourth Quarter 2015 Results on Thursday, February 11, 2016

PR Newswire January 28, 2016

AB Announces December 31, 2015 Assets Under Management

PR Newswire January 12, 2016

Grupo GICSA Appoints New Investor Relations Officer

Business Wire January 8, 2016

GICSA Announces its First Successful Issuance of Local Bonds in Mexican Market

Business Wire December 11, 2015

AB Science announces completion of patient recruitment for the phase 3 study of masitinib in amyotrophic lateral sclerosis (ALS)

GlobeNewswire December 8, 2015

AB Announces November 30, 2015 Assets Under Management

PR Newswire December 8, 2015

AB Science announces results from Phase 3 randomized placebo-controlled trial of masitinib in adults with severe systemic mastocytosis unresponsive to optimal symptomatic treatment

GlobeNewswire December 7, 2015

New AB research discovers three sharply different investor personas--and degrees of retirement readiness--among DC plan participants

PR Newswire December 3, 2015

AB becomes a Climate Bonds Partner

PR Newswire December 3, 2015